Lights and Shadows on Monoamine Oxidase Inhibition in Neuroprotective Pharmacological Therapies

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|11|22|2788-2796

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.11, Iss.22, 2011-11, pp. : 2788-2796

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Applications of Antioxidants: Lights and Shadows

By  

Current Drug Targets, Vol. 15, Iss. 13, 2014-12 ,pp. : 1177-1199

Bentham Science Publishers

Access to resources Recommend Favorite

Monoamine Oxidase Inhibition and CNS Immunodeficiency Infection

By Koutsilieri E.   Scheller C.   ter Meulen V.   Riederer P.  

Neurotoxicology, Vol. 25, Iss. 1, 2004-01 ,pp. : 267-270

Elsevier

Access to resources Recommend Favorite

Monoamine Oxidase-B Inhibition in Alzheimer's Disease

By Riederer P.   Danielczyk W.   Grunblatt E.  

Neurotoxicology, Vol. 25, Iss. 1, 2004-01 ,pp. : 271-277

Elsevier

Access to resources Recommend Favorite

Pyrazoline: A Promising Scaffold for the Inhibition of Monoamine Oxidase

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 13, Iss. 3, 2013-09 ,pp. : 195-206

Bentham Science Publishers

Access to resources Recommend Favorite

Monoamine Oxidase Inhibitors as Neuroprotective Agents in Age-Dependent Neurodegenerative Disorders

By  

Current Pharmaceutical Design, Vol. 16, Iss. 25, 2010-08 ,pp. : 2799-2817

Bentham Science Publishers

Access to resources Recommend Favorite